Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Dicoumarin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
BACKGROUND AND OBJECTIVES Calcific uraemic arteriolopathy (CUA), also known as calciphylaxis, is a rare but life-threatening… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
2009
2009
A new dicoumarin, named as dimeresculetin (1), together with another dicoumarin, euphorbetin (2) and esculetin (3) were isolated… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
Review
2009
Review
2009
AIMS Drug-eluting stents (DES) have never been sufficiently studied in patients with atrial fibrillation (AF). The latter are… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
Highly Cited
2003
Highly Cited
2003
BACKGROUND Dialysis patients with atrial fibrillation have an increased thrombolic risk. Dicoumarin anticoagulant therapy is… Expand
Highly Cited
2002
Highly Cited
2002
PURPOSE To assess the efficacy and safety of mechanical fragmentation combined with intrapulmonary thrombolysis in massive… Expand
Highly Cited
1995
Highly Cited
1995
Daphnoretin, a dicoumarin isolated from Wikstroemia indica C.A. Mey. (Thymelaceae), induced superoxide anion (O2-) formation in… Expand
1949
1949
The concept of prothrombin as the specific precursor of thrombin dates from the so-called classical theory of blood coagulation… Expand
1947
1947
ETIOLOGY OF MULTIPLE SCLEROSIS EVIDENCE has been accumulating over recent years which indicates that vascular destruction, or… Expand
1942
1942
One of the most interesting and challenging developments in the field of the biologic sciences in recent years has been the… Expand
1942
1942
The identification and synthesis of the hemorrhagic agent of hemorrhagic sweet clover disease, dicoumarin [3,3′-methylene-bis-(4… Expand